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Midline Catheter Usage in the Neonatal Population    
Neonatal sepsis is associated with increased mortality and morbidities which include 
lengthy hospital stays (Smith & Benjamin, 2011). Initially, the neonate may present with subtle 
signs and symptoms that are nonspecific to sepsis such as lethargy, temperature instability, 
irritability, and feeding intolerance (Kendall & Karlsen, 2012).  Due to the immaturity of the 
neonate’s immune system, and the high susceptibility of sepsis-associated mortality, neonates are 
commonly administered empirical antibiotics in the neonatal intensive care unit (NICU).  The 
most frequently prescribed therapeutics in neonates is the narrow-spectrum antibiotics ampicillin 
and gentamicin (Clark, Bloom, Spitzer, & Gerstmann, 2006).   
Guidelines, recommendations, and standards point to the need for evidence-based 
practices (EBP) when selecting a vascular access device (VAD) for administering intravenous 
treatments (Moureau & Chopra, 2016).  A midline catheter (MC) offers reliable access and 
provides better hemodilution versus a peripheral intravenous catheter (PIV) because the tip of the 
MC is placed in a larger diameter vein thus protecting the infant’s future vessel health 
(Rosenthal, 2008).    
 According to Nelson, Batalden and Godfrey (2007), setting goals that are considered 
stretched require extending oneself to the limit to be actualized.  This type of goal provides a 
higher standard of care to strive for.  As leaders, we must advocate for our patients by selecting a 
VAD with the lowest risk that most effectively supports the infant’s treatment plan based on 
available evidence and specified indications.  This project intends to do just that by advocating 
for a MC when appropriate in lieu of multiple PIVs. 
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Clinical Leadership Theme 
The Clinical Nurse Leader (CNL) is prepared for direct clinical leadership at the point of 
care (microsystem) to ensure that care delivery is safe, evidence-based, and targeted towards 
optimal quality outcomes for the cohort of clients they serve (Reid & Dennison, 2011). The CNL 
answers the call to rise above the disjointed stride of complex health care ensuring effective and 
safe care patient care (Porter-O'Grady, Clark, & Wiggins, 2010).  CNLs are invaluable at the 
bedside and are prepared to oversee a team-based approach to patient care with an expanded 
knowledge base in clinical decision-making, risk assessment, quality and safety, and EBP 
(AACN, 2013).   
The focus of this project is to reduce the number of PIV attempts on all neonates when 
empirical antibiotic therapy is needed by advocating for a MC as the appropriate VAD when a 
central line is not in use.  It is essential for the CNL to promote health policy and advocacy by 
leveraging social change, promoting wellness, improving care outcomes, and reducing costs 
(AACN, 2013).  As a Systems Analyst/ Risk Anticipator, it is necessary to perform a 
microsystem assessment, collect and analyze data in support of an EBP change then facilitate 
lateral integration.  This type of forward thinking will aid in the facilitating of ongoing and 
evolving communication, collaboration, coordination, and evaluation among the 
multidisciplinary team.  Promoting a sense of shared responsibility for patient outcomes is a key 
goal of the CNL (King & Gerard, 2016).    
The global aim is to reduce the pain and suffering on behalf of the neonate and their 
families in the NICU.  Nurses can advocate for their patients by identifying the need for a MC 
versus a PIV.  Best practice can be achieved by developing a policy and procedure (P&P) that 
identifies qualifiers and processes for MC placement for neonates who may require antibiotic 
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therapy for more than 48 hours.  The process begins with a review of the evidence-based 
literature to support the projected outcome of decreasing PIV attempts with the placement of a 
MC. The process ends with the completion of an evidence-based P&P that is approved by the 
Neonatal Joint Practice Committee.  By working on the process, expectations are: (1) the number 
of PIV insertion attempts will be reduced, (2) increase nurse education, advocacy, and 
collaboration with the ordering physician, (3) reduce pain in the neonate, (4) improve patient 
(family) satisfaction, (5) decrease costs, (6) reduce complications.  It is important to work on this 
now because neonates have difficult intravenous access (DIVA).  By advocating for the most 
appropriate VAD we can preserve the infant’s vessel health for future medical needs and reduce 
potential complications.    
Statement of the Problem 
Upon admission to the Mercy San Juan Medical Center’s (MSJC) NICU, most neonates 
are presumed septic.  With that being said, neonates are initially treated with ampicillin and 
gentamicin to prophylactically cover their immature immune systems.  One of the performance 
improvement and benchmarking initiatives in the NICU is a data driven partnership with the 
California Perinatal Quality Care Collaborative (CPQCC) called the antibiotic stewardship 
collaborative (ASC).  ASC recognizes the need to both preserve antimicrobial agents and 
increase antimicrobial resistance by using antibiotics appropriately.  These guidelines are 
adapted by NICUs so that the appropriate antibiotic selection, dosing, route and duration of 
antibiotic therapy will be applied.  The head of our Neonatology Department tracks a vast 
amount of pertinent data in an excel spreadsheet with regard to the CPQCC guidelines with one 
being the start and stop dates of antibiotic usage.  Implementation of EBP for optimizing 
antibiotic use has been endorsed by the American Academy of Pediatrics, the Centers for 
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Disease Control and Prevention, the Society of Healthcare Epidemiologists of America, and the 
Infectious Disease Society of America (CPQCC, 2016).   
Antibiotics are an essential treatment for sepsis in the neonate and the delivery of the 
medication is dependent upon the use of a VAD.  The initial VAD of choice is a PIV for 
antibiotics unless a central line is placed.  What prompted the attention of this project were the 
late preterm, term, or post-term neonates that were on full feedings and required antibiotic 
therapy for seven to fourteen days and only had a PIV as the primary modality.  MCs have many 
advantages for use in intravenous therapy and medications.  When inserted in a sterile 
environment and correctly monitored and maintained, they present lower rates of infection than 
previously suggested (Cummings, Hearse, McCutcheon, & Deuter, 2011).  Moreover, there is 
not a gold standard or predominant recommendation for the most appropriate VAD.  For 
example, Romesberg (2015) did not endorse the use of MCs in the NICU because there was a 
lack of sufficient evidence with regard to safety and efficacy. Additionally, Romesberg 
encourages the proliferation of randomized controlled trials to evaluate best practice for the 
reduction of infection rates and extravasation associated with VAD usage.  Based on the number 
of neonates that required empirical antibiotics, potential benefits of the use of MCs, and the lack 
of a prevailing recommendation for use in the NICU, this problem warrants further investigation. 
As a member of the peripherally inserted central catheter (PICC) team, I used the ASC 
excel spreadsheet to identify neonates that could have benefited from a MC due to DIVA, did not 
have a central line in place and were on antibiotics for an average of four to fifteen days.  Direct 
observation was made when neonates required multiple PIV attempts to complete the intended 
antibiotic regimen.  Nurse inquiry was obtained as to “why” these neonates did not have a more 
reliable VAD, such as a MC.  The resounding answer was the nurse had not asked for the order 
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for a MC placement because they did not think to collaborate with the physician and vice versa.  
The lack of patient advocacy and nurse to physician collaboration prompted a root cause analysis 
(Appendix A).  
Project Overview 
MSJC’s NICU is licensed for twenty-six beds.  It is considered a level III NICU in the 
Sacramento region.  It is equipped with the latest technology and specially trained staff to care 
for neonates who are seriously ill or born extremely premature (twenty-three-week gestation).  
The patient population of the NICU is composed of patients of high to moderate acuity and 
chronic complex neonates.  The NICU has been a leader in caring for the smallest of newborns 
with documented favorable outcomes.  The NICU actively participates in collecting and 
analyzing data for the Vermont Oxford Network which is a voluntary, international quality and 
safety consortium dedicated to improving the quality and safety of neonatal care (Vermont 
Oxford Network, 2014) 
The healthcare professionals who make up the Level III NICU include seven board 
certified neonatologists, neonatal nurse practitioners, a neonatal nurse educator, registered 
nurses, respiratory care practitioners, developmental specialists, lactation consultants, dietitians, 
and pharmacists. The NICU is equipped to provide specialized care including invasive 
monitoring, conventional ventilation, surgery, transport service, inhaled nitric oxide and high-
frequency oscillator ventilation and whole body cooling.  MSJ’s NICU also has a devoted 
neonatal transport team available twenty-four hours a day, seven days a week.  The transport 
team does everything possible to be at the delivery for outlying facilities for the emergent 
situations.  For 2016, the rate of admissions was 320 neonates.  The admission rate for 2017 to-
date is 204.   
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The project consists of reducing the number of PIV attempts on neonates by placing a 
MC for neonates requiring antibiotic therapy for greater than 48 hours and do not have a central 
line in place.  The project’s slogan is “You don’t need an order to advocate.”  The goal is to 
empower nurses through education on the appropriate risks/benefits for use of MCs.  The initial 
education will be an in-service to the nursing staff about the benefits of using a MC in the 
neonate who needs antibiotics for greater than 48 hours and does not have central line access.  
This will be done at the shift change huddle.  Several relevant articles will be housed in a binder 
entitled MC articles. The in-service will continue by asking them to identify what VAD is in use 
currently, at their patient’s bedside and to discuss the antibiotic treatment plan with the off going 
nurse.  Based on the education provided, the question that must be identified by both nurses is 
“does my patient meet the criteria for a MC?”  This ongoing educational piece will be deemed a 
“huddle and a hand-off” and will be done daily for two-weeks.  Providing this education to the 
nursing staff will support the nurses’ efforts and preparedness when collaborating with the 
physician about a potential change in the plan of care with regard to a VAD modification.  This 
promotes patient advocacy.   
Ineffective communication between the nurses and the physicians is a key factor in this 
project not succeeding.  In one study, the results suggested that enhancing the preparedness of 
nurses is essential to preventing communication breakdown among the healthcare team.  It 
further goes on to conclude that physicians need to reevaluate their personal attitude toward 
nursing practice in order to promote professionalism, responsiveness, and autonomy in the 
clinical setting (Farhadi, Elahi, & Jalali, 2016).  By the end of the two-week in-services, the 
huddle and a handoff will continue to be in place and the nurses will engage the physicians by 
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collaborating with them with regard to their patient’s VAD.  This ongoing dialogue between the 
nurse and the physician will strengthen and enhance the patient experience.   
The project attempts to diminish pain in the neonate by reducing the number of PIV 
attempts.  Data in newborns suggest that recurrent exposure to multiple painful stimuli early in 
life can lead to deviations in both brain development and stress responses that continue through 
childhood (Bannister, 2016). Lastly, the project aims to preserve the infant’s vessel health for the 
future.   Vessel health preservation gives nurses more autonomy to advocate for the appropriate 
VAD for their patients and improved knowledge around pH and osmolality of intravenous drugs 
(Weston, Nightingale, O'Loughlin, & Ventura, 2017).   
The specific aim of this project is to decrease the number of PIV attempts by 25% on 
neonates in the NICU by developing a P&P that identifies qualifiers and processes for MC 
placement for neonates who may require antibiotic therapy for more than 48 hours by December 
2017. The specific aim parallels the goals of the global aim, which is to reduce the pain and 
suffering on behalf of the neonate and their families in the NICU.  
Rationale 
This project is geared toward prevention and preservation. The septic neonate receives 
antibiotic therapy for approximately 7-10 days or longer depending on the severity of the 
bacteremia. Within that timeframe, PIVs are assessed and documented on hourly as infiltrations 
are common in the neonate.  Infiltration rates among neonates are as high as 57%–70% with 
extravasation occurring in 11–23% (Beall, Hall, Mulholland, & Gephart, 2013).  Compared with 
adults, their immature skin structures, flexible subcutaneous tissue, small blood vessels and poor 
venous integrity makes this vulnerable population susceptible to skin injury due to venipuncture 
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and intravenous infusions that can lead to extravasations (Beall, Hall, Mulholland, & Gephart, 
2013).   
A premature or sick infant may require multiple venous cannulations during a prolonged 
stay in the NICU and often veins that have previously been used may need to be re-cannulated.  
The practice of using PIV can pose many complications such as re-occurring infiltration when 
infusing vesicants.  Other potential risks resulting from of infiltration include increases in 
hospital-acquired harm, painful procedures, overuse of supplies, increased the length of stay, and 
nursing time; it threatens relationships essential in patient- and family-centered care (Wilt Major 
& Huey, 2016). An extravasation may lead to damage which may require surgical intervention, 
loss of function of the extremity at the site of injury and/or drawn out wound debridement 
(Hanrahan, 2013).  According to the hospital charge masters, Office of Statewide Health 
Planning and Development, the charge per day for NICU care at Mercy San Juan Medical Center 
is approximately $12,877.00/day (OSHPD, 2016). A SWOT analysis reviews the strengths, 
weaknesses, opportunities, and threats that surround this project (Appendix B). 
From the equipment supply and labor standpoint, per Goff (2013), the median cost of a 
single PIV attempt made by one nurse is approximately $41.00 and of that one attempt, 60% of 
nurses were successful.  Seventy-two percent of neonates had a successful PIV inserted in one to 
two attempts and accounted for 53% of the total costs. However, 28% of neonates required more 
than or equal to three PIV attempts and had a cost range of $69 to more than $125 per attempt, 
which consumed 43% of the total IV costs (Goff, 2013).  With regard to the retrospective chart 
audit that was dissected, based on the average of three infiltrations for a seven day course of 
antibiotics and labor costs for those replacement PIVs, this equates to approximately $300.00.  If 
a MC was placed using an all-inclusive kit, the approximate pricing would be $160.00 once.  
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A MC provides for better hemodilution because the tip of the catheter resides in a larger 
diameter of the vein (Moureau & Chopra, 2016). The MC is also more reliable than a PIV 
because it allows for a longer dwell time (Rosenthal, 2008).  From the data that was extrapolated 
from the ASC excel spread sheet, in 2016, there were twenty-three neonates that needed 
antibiotic therapy greater than 48 hours and only had PIV access.  From the retrospective chart 
audit, it was unclear as to how many PIV attempts were made so the median number used for 
cost analysis was three infiltrations per seven days of antibiotic treatment.  The cost to 
implement this project is approximately $65.00/hour for the CNL’s time.  It will cost 
approximately $130.00 per day for fourteen days to implement “a huddle and a handoff” which 
equates to $1,820.00 for the entire project to be implemented.  There will be no additional hourly 
costs for the nurses as they are already scheduled to work.   It is recognized that quality 
improvement projects can be costly therefore a cost analysis can help provide monetary data for 
stakeholders to evaluate (Appendix C).  The costs analysis reflects an overall $20.00 savings to 
implement this project. It is clear that the project pays for itself by preventing a lawsuit due to 
one extravasation.    
The price tag on an infant’s pain is extremely hard to quantify. According to Bhalla, 
Shepherd, and Tobia (2014), neonates were initially thought to have inadequate responses to 
painful stimuli. It was demonstrated that the developmental immaturity of the central nervous 
system makes the neonate more likely to feel pain. Watterberg et al. (2016) also found that  
untreated pain can have long-lasting physiologic and neurodevelopmental consequences which 
have future costs that cannot be identified within this scope of the project. 
Methodology 
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The goal of this project is to reduce the number of PIV attempts by 25% by the end of 
2017. Recognition that any change can be difficult is an understatement, especially in healthcare.  
Kurt Lewin’s (1951) Theory of Change identifies three stages through which change agents must 
proceed before change can become part of a system.  The stages are:  unfreezing (when change is 
needed); moving (when change is initiated); and refreezing (when equilibrium is established) 
(Mitchell, 2013) (Appendix D).  It is with great hope that this project empowers nurses to 
advocate for a MC in lieu of a PIV.  Working with the ordering physician will improve 
communication and collaboration with the healthcare team and empower the nurses while 
bringing about better patient outcomes for the neonates they care for.   
Before the implementation process began, an assessment of the type of VAD used for 
neonates meeting the above qualifications was done.  This process was done by retrospective 
chart audits from the ASC excel spread sheet.  The use of implementing routine audits in clinical 
practice is an effective tool in the selection and management process of VADs (Ray-Barruel, 
2017).  Based on this data collection from June 2016 through June 2017, it was discovered that 
approximately 43 babies needed antibiotic therapy and only had PIV access versus a MC access.  
The audit also found gaps with inconsistent documentation of PIV attempts.  Antibiotic 
stewardship is a coordinated program that endorses the appropriate use of antimicrobials, 
improves patient outcomes, reduces microbial resistance, and decreases the spread of infections 
caused by multidrug-resistant organisms (Patel & Saiman, 2012).  This demonstrated the 
unfreezing portion of the project for change.  
The first part of the implementation process will be to be placed on the agenda for the 
unit council meeting at the end of July 2017.  The unit council is composed of nurses (that have 
been appointed to the group by vote), management and the neonatal nurse practitioner (NNP).  
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Nurses' decisional involvement and participation in a unit council may serve as a venue to best 
utilize EBP skills with the overall goal of improving care outcomes (Macyk, 2017).  This is the 
moving or change phase of Lewin’s change theory.   
The third part of implementation is to draft an EBP P&P that is approved by the Neonatal 
Joint Practice Committee.  Once a P&P is approved, I will require the nurses to read and sign the 
new P&P which will be kept in policy tech for continued review.  There will also be an 
algorithm that clearly identifies which neonates meet criteria for a MC placement (Appendix E).  
This is the first part of instituting a newly acquired equilibrium.   
The last stage of Lewin’s change theory is to refreeze.  The refreezing phase is to prevent 
communication breakdown among the healthcare team.  I will meet with the doctors, pharmacist, 
nurse practitioner and charge nurse at the antibiotic stewardship timeout when there is an infant 
that meets the criteria for antibiotic therapy for greater than 48-hours.  This checklist is initiated 
on any infant that meets criteria and is based on CPQCC guidelines.  I will update the antibiotic 
48 hour timeout check list to include a VAD section.  If the VAD section is added to the 
checklist, a dialogue about which VAD is appropriate for the intended duration of antibiotic 
therapy will aid in a more effective collaboration with all of the healthcare team.  The head of 
neonatology has acknowledged the need for this addition to the checklist.   
For the evaluation portion of my project, I will use the individual checklists from each 
neonate that meets the project’s MC criteria, by posing three questions to the physicians: 1) Is a 
MC reasonable for the intended antibiotic therapy for this infant?  2) Did the nurse ask for an 
order for a MC placement? 3) Was a MC placed? I will add three columns in the ASC excel 
spreadsheet to represent the three questions I posed (Appendix H).  The title on the columns will 
be identified as “Q1, Q2, and Q3 and will use a simple “Y” or “N” for the three questions 
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respectively to see if my goal of a 25% reduction in PIV attempts has been made.  This 
evaluation tool helps me to quantify nurse advocacy for those neonates that meet the MC criteria.  
The final evaluation will be to continue to chart audit those specific neonates that meet this 
criteria. Data triangulation is a powerful technique that will facilitate validation of data through 
cross verification from two or more sources.  This is how I will evaluate the process and 
readdress education where needed by directly addressing individual nurses as I will be able to 
see from the checklist which baby is assigned to which nurse.    
Data Source/Literature Review 
The literature compiled for this project supports the concept of placing midline catheters 
in neonates that require empirical antibiotic therapy for greater than 48 hours when certain 
criteria are met.  The following PICO was used: 
●    P: Neonates that are septic 
●    I: Use a MC in neonates who require antibiotic therapy for greater than  
48 hours and do not have central line access. 
●    C: Using the MC in the neonatal population vs the current practice of using multiple 
PIVs for antibiotics greater than 48 hours  
●    O: Reduce the number of PIV attempts which will decrease pain in the neonate. 
My initial literature search was “neonates and VAD” which generated more articles for 
central line access (e.g. peripherally inserted central catheter) versus midline access.  I did have 
to look at some adult/pediatric population articles that I could transpose onto the neonatal 
population.  I also thought of the other potential barriers that would transpire which would not 
make my CNL project successful which is the communication and collaboration between nurses 
and physicians.  I was able to review many articles with regard to that issue.  I also wanted to see 
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if my hypothesis was correct when using a MC in lieu of a PIV concerning a decrease in costs.  
That research was substantiated. I was also able to find specific articles regarding decreasing 
procedural pain in the neonate.  The following literature review demonstrates the different 
strategies that support this project.   
In a study by Adams, Little, Vinsant, and Khandelwal (2016), the authors compare VAD 
indications and complications by highlighting the use of midline catheters as a possible cost-
effective and safe approach for a VAD.  The average dwell time of a MC is reported as 7.69-16.4 
days, which surpasses PIVs (2.9-4.1 days) and is comparable to PICCs (7.3-16.6 days). The cost 
of insertion of a MC has been cited as comparable to three PIVs, and their use has been 
associated with noteworthy cost savings.  The MC is a useful VAD with a low complication rate, 
longer dwell time, and has a high rate of first-attempt placement. 
In a study performed by Cummings, Hearse, McCutcheon, and Deuter (2011), MCs have 
many advantages for chronically ill patients needing up to six weeks of intravenous therapy.  
MCs that are inserted in a sterile environment and are monitored and maintained correctly have a 
significantly lower association of infection and thrombus than previously suggested studies.  
MCs were monitored for twelve months following the conclusion of the trial and infection rates 
continued to be below one percent and thrombus rates lower than two percent. 
Hugill (2016) aimed to increase knowledge and understanding of issues relating to 
choosing and using VADs in the neonatal patient population. This article highlights the 
importance of appropriate device and insertion site selection, skin preparation, and aftercare. 
Paying due attention to these aspects is an essential component of the neonatal nurse's role and 
ensures that the risks of adverse events are minimized.   
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Moureau and Chopra (2016) summarize the work and recommendations of the panel for 
the Michigan Appropriateness Guide for Intravenous Catheters.  The study advocates for patients 
with DIVA, to determining the VAD with the lowest risk that best meets the needs of the 
treatment plan is key.  Specifically for MCs, recommendations for this VAD are suitable for 
patients with peripherally compatible solutions or medications where treatment is between six to 
fourteen days.   
The study of Romesberg (2015), pertains to MC use in the NICU patient.  This discussion 
includes information pertaining to the historical perspective of MC use, devices currently in use, 
common sites for placement, average dwell times, associated costs, and acceptable fluids and 
medications for infusion through MCs. 
Rosenthal (2008) asserts that a single attempt at a MC can meet the infusion therapy 
needs of a patient who requires more than five days of intravenous therapy, has poor or limited 
peripheral access or needs reliable access. The patient doesn't have to be “stuck” multiple times 
for I.V. attempts which can be a frequent complaint on patient satisfaction surveys.   
Timeline 
The projected timeline encompasses a total of six months.  The most time-consuming 
portion of the project is the retrospective chart audits.  I accessed the ASC excel spreadsheet to 
gather data for a one year period.  MSJs NICU started the antibiotic stewardship in June 2016.  I 
wanted to have one year of data to review and am waiting for the June 2017 data to be entered so 
the data collection is ongoing. 
 The second part of the implementation process will be to be placed on the agenda at the 
unit council meeting at the end of July 2017. This is where the preliminary meeting with 
stakeholders involved can look at my data and add feedback.  This is also the venue for more 
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data collection, brainstorming, and project planning to take place.  This is in the form of a Gantt 
chart (Appendix F).     
The third part of implementation is to draft an EBP P&P that is approved by the Neonatal 
Joint Practice Committee.  This may take several attempts due to physician availability and 
physician treatment preferences.  The projected date for the committee meeting is October 2017, 
however, this is flexible due to management turnover and physician availability.  The biggest 
obstacle is the current turnover in upper and middle management.  My timeline has been skewed 
due to this.  
Expected Results 
The expected goal of this project is to reduce the number of PIV attempts by 25% by the 
end of 2017. I have been able to implement the project’s slogan “You don’t need an order to 
advocate.”  The goal behind the slogan is to empower nurses through education on the 
appropriate use and risks/benefits of MCs.  Implementation of the educational in-services to the 
nursing staff is on track.  This will be done at the shift change huddle.  The in-service will 
conclude by asking them to identify what VAD is in use currently, at their patient’s bedside and 
to discuss the antibiotic treatment plan with the off going nurse.  It is an expectation that the 
question will be asked by both nurses, “Does my patient meet the criteria for a MC instead of a 
PIV?”  This “huddle and a handoff” will also be an expectation for the nurse to continue in their 
bedside practice for all neonates needing antibiotic therapy.  This promotes patient advocacy.  
Other expectations of this project are to reduce pain in the neonate which will, in turn, improve 
patient (family) satisfaction, decrease equipment, and labor costs and to reduce complications 
due to infiltrations and/or extravasations.  It is also my continued expectation that the RNs and 
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physicians will collaborate with each other for the betterment of keeping the infant as the center 
of care.   
Nursing Relevance 
There is a growing expectation among the public that the medical services available to 
them should be able to produce evidence of the fact that they are as good as those elsewhere 
(benchmarking).  Satisfactory national data to underpin performance management and 
benchmarking remain somewhat difficult to quantify or qualify in the NICU.  According to 
Wennberg (2010), as a standard rule, studies find wide variation in resource use and little 
relationship with patient outcomes; thereby challenging the belief that directing incrementally 
more resources at certain health care problems necessarily produces incrementally better results. 
More care is not always better. 
Wirtschafter et al. (2011) opened a discussion about an aspect of NICU care for which 
evaluation and benchmarking are quite problematic. When infection is difficult to prove, such as 
in the case of culture negative sepsis, what constitutes overuse or underuse of antibiotics?  That 
being said, my project relies on the question “to treat or not to treat”.  In the instance for treating 
neonates for sepsis with antibiotics for greater than 48 hours, my project is geared toward vessel 
preservation.  It is of the utmost importance to provide the right VAD for the right patient at the 
right time.  Advantages of a MC include, they provide longer indwelling time, up to 28 days 
according to the IV Nurses Society (2016), and provide IV access for neonates with DIVA 
(Moureau & Chopra, 2016), and decreased risk of infections compared to other central VADs 
(Moureau et al., 2015).  
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Summary Report 
The specific aim again is to decrease the number of PIV attempts by 25% on neonates in 
the NICU by developing a policy and procedure that identifies qualifiers and processes for MC 
placement for neonates who may require antibiotic therapy for more than 48 hours by December 
2017.  This change must be approved by the Neonatal Joint Practice Committee.  The Plan-Do-
Study-Act (PDSA) worksheet is a useful tool for documenting a practice change. The tool 
includes developing a plan to test the change (Plan), carrying out the test (Do), observing and 
learning from the consequences (Study), and determining what modifications should be made to 
the test (Act) (IHI, 2017).  Using the IHI model I identified what practice change I wanted to 
accomplish within my microsystem population, set a specific aim for the improvement with a 
specific time frame, created the direction in which I wanted my project to proceed, evaluate the 
expected results and then finally learn from any mistakes or modifications.  The PDSA cycle is 
summarized in the below paragraphs (Appendix G). 
In the planning stage of my project, I initially performed a retrospective chart audit based 
on the data in the ASC excel spread sheet.  The admission rates into the NICU from 2016 and 
2017 used as the denominator when calculating the percent of neonates that had multiple PIVs 
versus MCs as the appropriate VAD.  The date is as follows: 
• Admission rate for 2016 = 320 neonates 
23 neonates had multiple PIVs versus MCs as the most appropriate VAD = 7.5% 
• Admission rate for 2017 (to date) = 204 neonates 
20 neonates had multiple PIVs versus MCs as the most appropriate VAD = 10% 
The average PIV attempt was 2.5  however there were gaps in consistency with 
documentation of PIV attempts in the EMR thus data could not be fully verified. 
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Next, I was placed on the agenda for the unit council meeting to discuss my project at the 
end of July 2017.  The unit council is composed of nurses (that have been appointed to the group 
by vote), management and the neonatal nurse practitioner (NNP).  In this forum, my data can be 
presented and studies involving best practices can be discussed using the evidence that I have 
already discovered.  Once I have buy- in from the unit council, I will move directly into in-
servicing the nurses at the change of shift huddles.   
The doing phase started with creating a slogan for the project entitled “You don’t need an 
order to advocate” which brands the education segment of the project.  This was done at the 
change of shift huddle.  The goal was to empower nurses through education on the appropriate 
use of MCs.  The educational portion was about the risks/benefits of using a MC in the neonate 
who needs antibiotics for greater than 48 hours and does not have central line access in lieu of a 
PIV.   Several relevant articles were housed in a binder entitled MC articles and placed at the 
charge nurse station educational for re-enforcement.    
In-services will continue by asking them to identify what VAD is in use currently, at their 
patient’s bedside and to discuss the antibiotic treatment plan with the off going nurse.  Based on 
the education provided, the question that must be identified by both nurses will be “does my 
patient need a MC?”  This ongoing educational piece initiated in the shift change huddle will be 
deemed a “huddle and a hand-off.”  The goal for this phase is to support the nurses’ efforts to 
advocate for a potential change in the plan of care with regard to a VAD modification when 
collaborating with the physician.   
Studying and evaluating what went right and what went wrong with the project is an 
essential component of this project.  This is the area by which modifications to the project can 
take place.  I will use the neonate’s individual antibiotic 48-hour timeout checklist that meets the 
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project’s MC criteria.  From this, I will pose three questions to the physicians: 1) is a MC 
reasonable for the intended antibiotic therapy for this infant?  2) Did the nurse ask for an order 
for a MC placement? 3) Was a MC placed? I will update my ASC excel spreadsheet in the 
columns identified as “Q1, Q2, and Q3 and will use a simple “Y” or “N” for the three questions 
respectively to see if my goal of a 25% reduction in PIV attempts has been made 
Drafting an EBP P&P that is approved by the Neonatal Joint Practice Committee is the 
act in the PDSA cycle.  Once a P&P is approved, I will require the nurses to read and sign the 
new P&P and will keep an electronic version of it in policy tech for continued review.  There 
will also be an algorithm that clearly identifies which neonates meet criteria for a MC placement.   
As of this date, the unit council has been disbanded however I did get permission from 
the head of the Neonatology Department to being with the “do” and the “study” portion of the 
PDSA cycle.  The act portion which entails drafting an EBP P&P for MC placement will have to 
wait until the Neonatal Joint Practice Committee meets and approves the P&P.  It is encouraging 
to know that there is already some physician buy-in.  It was uncovered that not all of the 
neonatologists are participating in the antibiotic 48-hour timeout.     
Conclusion  
Neonatal sepsis is associated with increased mortality and morbidities which include 
lengthy hospital stays.  The project attempts to address the way the healthcare team administers 
empirical antibiotics using the most appropriate VAD.  By implanting this project to fruition, all 
members of the healthcare team can be empowered to advocate and collaborate with each other 
so that pain and suffering can be reduced by decreasing the number of PIV attempts which will 
lead to improving patient (family) satisfaction, decrease costs and preserve the neonate’s future 
vessel health.  Guidelines, recommendations, and standards of practice such as the creation of a 
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P&P for a MC is of the utmost importance and will provide a practice change to achieve the 
specific aim of reducing the number of PIV attempts in neonates by 25% by the end of 2017.   
To be able to track the appropriate VAD used for antibiotic therapy, continued chart 
audits must be done.  However, further education to the nursing staff will be needed for correct 
documentation in the EMR addressing the number of vessel cannulations performed with any 
VAD used.  Data collection from the original retrospective chart audit uncovered inconsistent 
documentation in the EMR around the number of PIV attempted.  An additional project isolating 
this gap is warranted. 
The main take away of what I learned from this project is that nurses lack the confidence 
to collaborate with physicians.  To accomplish the projects primary theme of patient advocacy, 
doing an anonymous pre-implementation questionnaire that encourages staff to be truthful as to 
their perceived knowledge, skills and confidence level in collaborating with physicians would 
greatly benefit this project and any future endeavors.  By continuing this project it is my hope to 
encourage the nurses to become paladins which is defined as one who is a determined advocate 
or defender of a noble cause.  This highly vulnerable population is in need of this type of nurse.   
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Appendix A 
Root Cause Analysis- Fish Bone Diagram 
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Appendix B 
SWOT Analysis 
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Appendix C 
Cost Analysis 
 
Current PIV 
Intervention  
Treatment of 
Extravasation 
 
 
    
 Price per unit  $40.00    
 ~3 infiltrations per 7 days  $120.00    
 RN/hr (60.00/hr) x3 
infiltrates $180.00    
 Total cost for PIV for 7 days  $300.00   
 
 
    
 Hyaluronidase -    $105.00/dose 
 Surgical Intervention   2,500.00 
 Litigation   $100, 000- $500,000+/case 
 
 
    
 
 
Proposed 
Midline   
 Price per unit  $160.00    
 RN hr cost x1 $60.00    
 Total cost for first attempt 
midline placement   $220.00    
 
 
    
 
 
    
 
 
    
 
 
    
 Conclusion:     
 Aug 2016 there was 23 
neonates requiring 
antibiotic treatment 
greater than 48hrs and had 
a PIV (~3 infiltrations per 7 
days    $6,900.00    
 Proposed Midline 
intervention for 23 babies  $5,060.00    
 Labor and costs savings $1,840.00    
 Project Cost  $1,820.00   
  
All costs are approximated 
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Appendix D 
Lewin’s Model of Change 
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Appendix E 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neonates who require antibiotic therapy for > 48 hours 
ours 
 
 
YES NO 
STOP 
CENTRAL LINE IN USE 
YES NO 
STOP 
MIDLINE ORDERED 
YES 
MIDLINE PLACED 
NO 
ASK MD FOR 
ORDER 
MIDLINE PLACED Not indicated per MD 
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Appendix F 
 
Gantt Timeline 
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Appendix G 
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Appendix H 
Antibiotic Stewardship Excel Spread Sheet 
 
 
Patient Name Medical Record # Date of Birth Gestational Age Signs of Infection Antibiotics started Antibiotics Starting date Antibiotic stopping date Length of treatment Q1 Q2 Q3
